Issue navigation
Volume 58, Issue Supplement_2, March 2019
Abstracts of the 19th International Vasculitis and ANCA Workshop
RHEUMATOLOGY 2019 ABSTRACTS
ANCA AND OTHER BIOMARKERS
001. URINARY SOLUBLE CD163 AND ACTIVE CRESCENTIC GLOMERULONEPHRITIS IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057, https://doi.org/10.1093/rheumatology/kez057
002. HYDRAZINE INDUCED ANCA-ASSOCIATED VASCULITIS: A UNIQUE PRESENTATION OF AN ULCERATIVE VARIANT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.001, https://doi.org/10.1093/rheumatology/kez057.001
003. CELL-FREE MITOCHONDRIAL BUT NOT NUCLEAR DNA CORRELATE WITH DISEASE ACTIVITY IN ANCA ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.002, https://doi.org/10.1093/rheumatology/kez057.002
004. USEFULNESS OF BIOMARKERS OF EOSINOPHIL ACTIVATION IN MONITORING EGPA DISEASE ACTIVITY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.003, https://doi.org/10.1093/rheumatology/kez057.003
005. COMPARATIVE EVALUATION OF RADIOGRAPHIC AND AUTOIMMUNE SEROLOGIC FEATURES BETWEEN ANCA- ASSOCIATED ILD AND IPAF
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.004, https://doi.org/10.1093/rheumatology/kez057.004
006. ANCA-ASSOCIATED VASCULITIS: IS THERAPY THE LESSER EVIL?
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.005, https://doi.org/10.1093/rheumatology/kez057.005
007. ANCA-ASSOCIATED INTERSTITIAL LUNG DISEASE: THE VANDERBILT EXPERIENCE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.006, https://doi.org/10.1093/rheumatology/kez057.006
008. ANCA BEYOND MPO & PR-3: THE CLINICAL UTILITY OF AN EXPANDED ANCA PROFILE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.007, https://doi.org/10.1093/rheumatology/kez057.007
009. UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 AND CALPROTECTIN IN ASSESSING DISEASE ACTIVITY IN ANCA-ASSOCIATED RENAL VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.008, https://doi.org/10.1093/rheumatology/kez057.008
010. QUALITY IMPROVEMENT PROJECT: IMPLEMENTING NEW ‘ANCA SAMPLE’ PATHWAY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.009, https://doi.org/10.1093/rheumatology/kez057.009
011. CHORIORETINAL THICKNESS TRACKS DISEASE ACTIVITY IN CLINICAL ANCA VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.010, https://doi.org/10.1093/rheumatology/kez057.010
012. SERUM BIOMARKER PROFILE OF INDIAN PATIENTS WITH TAKAYASU’S ARTERITIS: RELATION WITH EARLY AND LATE ANGIOGRAPHIC PROGRESSION
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.011, https://doi.org/10.1093/rheumatology/kez057.011
013. PERCUTANEOUS LYMPH NODE BIOPSY TO EXPLORE IMMUNE DYSREGULATION IN VASCULITIS: A PILOT PROJECT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.012, https://doi.org/10.1093/rheumatology/kez057.012
014. DIFFERENTIAL PROTEIN EXPRESSION PROFILING OF AUTOIMMUNE DISEASES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.013, https://doi.org/10.1093/rheumatology/kez057.013
015. PREDICTORS OF SEVERE CRANIAL ISCHEMIC COMPLICATIONS IN GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.014, https://doi.org/10.1093/rheumatology/kez057.014
016. A PANEL OF SERUM AND URINARY BIOMARKERS HELPS TO DIFFERENTIATE BIOPSY FINDINGS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.015, https://doi.org/10.1093/rheumatology/kez057.015
017. SUBTYPES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS ACCORDING TO RHEUMATOID FACTOR
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.016, https://doi.org/10.1093/rheumatology/kez057.016
018. ANTI-NEUTROPHIL EXTRACELLULAR TRAP ANTIBODY IN PATIENTS WITH MICROSCOPIC POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.017, https://doi.org/10.1093/rheumatology/kez057.017
019. PENTRAXIN-3 PLASMA LEVELS AND GENE POLYMORPHISMS IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.018, https://doi.org/10.1093/rheumatology/kez057.018
020. IDENTIFICATION OF TARGET ANTIGENS FOR ANTI-ENDOTHELIAL CELL ANTIBODIES IN PATIENTS WITH TAKAYASU’S ARTERITIS USING PROTEOMICS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.019, https://doi.org/10.1093/rheumatology/kez057.019
021. INTERLEUKIN-27 IN TAKAYASU’S ARTERITIS: SERUM LEVELS AND RELATIONSHIP WITH DISEASE ACTIVITY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.020, https://doi.org/10.1093/rheumatology/kez057.020
022. RENAL AND SERUM EXPRESSION OF SIGLEC-9 IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.021, https://doi.org/10.1093/rheumatology/kez057.021
023. UTILITY OF SERUM FREE LIGHT CHAINS, ANTIPHOSPHOLIPID ANTIBODIES, AND CYTOKINES IN GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.022, https://doi.org/10.1093/rheumatology/kez057.022
024. A CASE OF CHOLESTEROL EMBOLIZATION SYNDROME WITH POSITIVITY OF MPO-ANCA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.023, https://doi.org/10.1093/rheumatology/kez057.023
025. CYTOKINE AND CHEMOKINE EXPRESSION IN SERUM AND NASAL MUCOSA IN GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.024, https://doi.org/10.1093/rheumatology/kez057.024
026. ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY (ANCA) ASSOCIATED GLOMERULONEPHRITIS SUPERIMPOSED ON CLINICALLY INSIGNIFICANT IGA NEPHROPATHY (IGAN): A CASE SERIES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.025, https://doi.org/10.1093/rheumatology/kez057.025
027. ANCA STATUS IN EOSINOPHIL GRANULOMATOSIS WITH POLYANGIITIS: A MONOCENTRIC COHORT ANALYSIS OF MANIFESTATIONS AND RELAPSES OF ANCA-POSITIVE AND ANCA-NEGATIVE PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.026, https://doi.org/10.1093/rheumatology/kez057.026
028. ANCA-MPO ANTIBODIES OF IGA ISOTYPE IN ANCA-ASSOCIATED VASCULITIS: PREVALENCE AND CLINICAL ASSOCIATIONS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.027, https://doi.org/10.1093/rheumatology/kez057.027
029. PR3-ANCA STATUS FOLLOWING RITUXIMAB: A USEFUL BIOMARKER FOR RELAPSE PREDICTION IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.028, https://doi.org/10.1093/rheumatology/kez057.028
030. TOLERABILITY AND CELL YIELD FROM NASAL BIOPSIES OBTAINED IN THE OUTPATIENT SETTING
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.029, https://doi.org/10.1093/rheumatology/kez057.029
031. PLATELETS AMPLIFY INFLAMMATION IN ANCA-ASSOCIATED VASCULITIS VIA MICROPARTICLES PRODUCTION AND HIGH-EXPRESSED BIOACTIVE MOLECULES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.030, https://doi.org/10.1093/rheumatology/kez057.030
032. PREVALENCE OF LACTOFERRIN AND ELASTASE IN NORTH INDIAN COHORT OF ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.031, https://doi.org/10.1093/rheumatology/kez057.031
033. URINE CALPROTECTIN AS DISEASE ACTIVITY AND PROGNOSTIC BIOMARKER IN ANCA-ASSOCIATED VASCULITIS (AAV)
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.032, https://doi.org/10.1093/rheumatology/kez057.032
034. DOES THE PRESENCE OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES CHANGE THE CLINICAL FEATURES AND PROGNOSIS IN GRANULOMATOSIS WITH POLYANGIITIS?
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.033, https://doi.org/10.1093/rheumatology/kez057.033
035. CANDIDATE BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS IDENTIFIED USING A PROTEOMIC APPROACH
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.034, https://doi.org/10.1093/rheumatology/kez057.034
036. USCD163 IS AN EARLY PREDICTOR OF TREATMENT RESPONSE IN CRESCENTIC GLOMERULONEPHRITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.035, https://doi.org/10.1093/rheumatology/kez057.035
037. CONSEQUENCES OF UREA AND SALT TREATMENT ON ANCA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.036, https://doi.org/10.1093/rheumatology/kez057.036
038. CLINICOPATHOLOGICAL CORRELATION IN SKIN BIOPSY SPECIMEN IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): ANALYSIS OF SEVEN CASES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.037, https://doi.org/10.1093/rheumatology/kez057.037
039. ANTI-PENTRAXIN-3 AUTOANTIBODIES IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.038, https://doi.org/10.1093/rheumatology/kez057.038
040. PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRITIS WITH P-ANCA POSITIVITY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.039, https://doi.org/10.1093/rheumatology/kez057.039
041. ANCA ASSOCIATED VASCULITIS IN SYSTEMIC SCLEROSIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.040, https://doi.org/10.1093/rheumatology/kez057.040
042. PROFILING THE AUTOANTIBODY REPERTOIRE IN VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.041, https://doi.org/10.1093/rheumatology/kez057.041
043. SUBGLOTTIC STENOSIS AND ENDOBRONCHIAL DISEASE IN GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.042, https://doi.org/10.1093/rheumatology/kez057.042
044. FALSE POSITIVES ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES BY INDIRECT IMMUNOFLUORESCENCE IN THE IMMUNOLOGY LABORATORY ROUTINE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.043, https://doi.org/10.1093/rheumatology/kez057.043
045. EVALUATION OF NOVEL SERUM BIOMARKERS OF DISEASE ACTIVITY IN GIANT CELL ARTERITIS, TAKAYASU’S ARTERITIS, POLYARTERITIS NODOSA, AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.044, https://doi.org/10.1093/rheumatology/kez057.044
046. ENDOTHELIN-1 TYPE A RECEPTOR EXPRESSION IN KIDNEY BIOPSIES OF PATIENTS WITH RENAL ANCA-ASSOCIATED VASCULITIS PREDICTS GLOMERULAR FILTRATION RATE DECLINE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.045, https://doi.org/10.1093/rheumatology/kez057.045
047. CLONAL HEMATOPOIESIS IN PATIENTS WITH ANCA-ASSCOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.046, https://doi.org/10.1093/rheumatology/kez057.046
048. INCREASED SENSITIVITY FOR PR3-ANCA USING A NOVEL CHEMILUMINESCENCE IMMUNOASSAY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.047, https://doi.org/10.1093/rheumatology/kez057.047
049. RITUXIMAB THERAPY FOR REFRACTOR/RELAPSING GRANULOMATOUS MANIFESTATIONS DUES TO GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.048, https://doi.org/10.1093/rheumatology/kez057.048
050. URINARY REGULATORY T-LYMPHOCYTES IDENTIFY ACTIVE RENAL ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.049, https://doi.org/10.1093/rheumatology/kez057.049
051. MOESIN EXPRESSION LEVEL OF MPO-ANCA ASSOCIATED-VASCULITIS MODEL MICE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.050, https://doi.org/10.1093/rheumatology/kez057.050
052. THE EFFICACY OF MEASURING THE ANTI-MOESIN ANTIBODY TITER IN THE PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS LIMITED TO THE UPPER RESPIRATORY TRACT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.051, https://doi.org/10.1093/rheumatology/kez057.051
053. CLINICAL UTILITY OF SERIAL MEASUREMENTS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES TARGETING PROTEINASE 3 IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.052, https://doi.org/10.1093/rheumatology/kez057.052
054. LOW DENSITY GRANULOCYTES IN ANCA VASCULITIS: PHENOTYPE AND FUNCTION
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.053, https://doi.org/10.1093/rheumatology/kez057.053
055. HIGH SERUM ANGIOPOIETIN-2 LEVELS IDENTIFY LARGE VESSEL INFLAMMATION IN PATIENTS WITH POLYMYALGIA RHEUMATICA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.054, https://doi.org/10.1093/rheumatology/kez057.054
056. SERUM TRANSFORMING GROWTH FACTOR-B IN TAKAYASU ARTERITIS – A CLUE FOR A POTENTIAL FAILURE OF THIS ANTI- INFLAMMATORY PATHWAY IN ARTERIAL INFLAMMATION?
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.055, https://doi.org/10.1093/rheumatology/kez057.055
057. PLASMA INDICATORS OF NETOSIS AS POTENTIAL ACTIVITY MARKERS IN GRANULOMATOSIS WITH POLYANGIITIS (GPA)
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.056, https://doi.org/10.1093/rheumatology/kez057.056
058. ANTINEUTROPHIL CITOPLASMIC ANTIBODIES IN THE REAL WORLD: RESULTS: FROM A SURVEY IN A GENERAL LABORATORY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.057, https://doi.org/10.1093/rheumatology/kez057.057
059. THE REVERSIBLE DIPEPTIDYL PEPTIDASE 1 INHIBITOR, INS1007, DECREASES SURFACE PROTEINASE 3 EXPRESSION AND NEUTROPHIL SERINE PROTEASE ACTIVITIES IN HUMAN NEUTROPHILS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.058, https://doi.org/10.1093/rheumatology/kez057.058
DIAGNOSIS/CLASSIFICATION
060. GRANULOMATOSIS WITH POLYANGIITIS AND INTERSTITIAL LUNG DISEASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058, https://doi.org/10.1093/rheumatology/kez058
061. UTILITY OF HIGH DEFINITION MRI IN MONITORING DISEASE ACTIVITY IN TAKAYASU ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.001, https://doi.org/10.1093/rheumatology/kez058.001
062. UPPER AND LOWER RESPIRATORY TRACT INVOLVEMENT IS SIMILAR IN MPO-ANCA AND PR3-ANCA GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.002, https://doi.org/10.1093/rheumatology/kez058.002
063. ASSESSMENT OF FEMORAL VEIN THICKNESS WITH DOPPLER US CAN BE A DIAGNOSTIC TOOL FOR BEHÇET’S DISEASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.003, https://doi.org/10.1093/rheumatology/kez058.003
064. ISOLATED PULMONARY VASCULITIS DIAGNOSED HISTOPATHOLOGICALLY AFTER PULMONARY ENDARTERECTOMY: A CASE SERIES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.004, https://doi.org/10.1093/rheumatology/kez058.004
065. HOW IS DIFFICULT TO MAKE ANCA ASSOCIATED VASCULITIS DIAGNOSIS IN EMERGENCY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.005, https://doi.org/10.1093/rheumatology/kez058.005
066. HISTOLOGIC AND CLINICAL PROGRESSION OF ANCA-ASSOCIATED GLOMERULONEPHRITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.006, https://doi.org/10.1093/rheumatology/kez058.006
067. PULMONARY INVOLVEMENT IN GIANT CELL ARTERITIS MIMIC
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.007, https://doi.org/10.1093/rheumatology/kez058.007
068. GRANULOMATOSIS WITH POLYANGIITIS - THE NECESSITY OF A RAPID DIAGNOSIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.008, https://doi.org/10.1093/rheumatology/kez058.008
069. DOES ANTI-GLOMERULAR BASEMENT (ANTI-GBM) ANTIBODY POSITIVITY CORRELATE WITH RELAPSE IN PATIENTS WITH ANTI-GBM DISEASE?
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.009, https://doi.org/10.1093/rheumatology/kez058.009
070. OUTCOMES FOLLOWING INTRODUCTION OF A RAPID ACCESS TEMPORAL ARTERY BIOPSY PATHWAY IN A TERTIARY AUSTRALIAN HOSPITAL
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.010, https://doi.org/10.1093/rheumatology/kez058.010
071. ANCA ASSOCIATED MESENTERIC VASCULITIS IN SYSTEMIC LUPUS ERITHEMATOSUS (SLE) TREATED WITH INTRAVENOUS IMMUNOGLOBULIN (IVIG)
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.011, https://doi.org/10.1093/rheumatology/kez058.011
072. ATRIAL MYXOMA MASQUERADING AS RETINAL VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.012, https://doi.org/10.1093/rheumatology/kez058.012
073. RHEUMATOID VASCULITIS AND POLYARTERITIS NODOSA: THE ROLE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.013, https://doi.org/10.1093/rheumatology/kez058.013
074. AFTER ALL, STILL A MAGNIFICENT IMPERSONATOR
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.014, https://doi.org/10.1093/rheumatology/kez058.014
075. DIFFERENCES IN LUNG HIGH-RESOLUTION COMPUTED TOMOGRAPHY FINDINGS BETWEEN PATIENTS WITH MICROSCOPIC POLYANGIITIS AND INTERSTITIAL LUNG DISEASE, AND PATIENTS WITH MPO-ANCA POSITIVE INTERSTITIAL LUNG DISEASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.015, https://doi.org/10.1093/rheumatology/kez058.015
076. RISK FACTORS ASSOCIATED WITH PERIPHERAL NEUROPATHY IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.016, https://doi.org/10.1093/rheumatology/kez058.016
077. CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.017, https://doi.org/10.1093/rheumatology/kez058.017
078. DIFFICULT AND DELAYED DIAGNOSIS OF PROSTATIC INVOLVEMENT IN GRANULOMATOSIS WITH POLYANGIITIS: TWO CASE REPORTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.018, https://doi.org/10.1093/rheumatology/kez058.018
079. HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A POSSIBLE CAUSE OF VENOUS-THROMBOEMBOLISM (VTE) IN ACTIVE SYSTEMIC VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.019, https://doi.org/10.1093/rheumatology/kez058.019
080. MULTIPLE KIDNEY MASSES IN A YOUNG MAN
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.020, https://doi.org/10.1093/rheumatology/kez058.020
081. SPONTANEOUS SPINAL SUBDURAL HEMATHOMA AS A MANIFESTATION OF ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.021, https://doi.org/10.1093/rheumatology/kez058.021
082. CLINICAL SUBSETS IN GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.022, https://doi.org/10.1093/rheumatology/kez058.022
083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.023, https://doi.org/10.1093/rheumatology/kez058.023
084. DISCOVERY AND VALIDATION OF A NOVEL ANGIOGRAPHIC CLASSIFICATION SCHEME IN TAKAYASU’S ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.024, https://doi.org/10.1093/rheumatology/kez058.024
085. THE ANTEROMEDIAL ULTRASOUND EXAMINATION OF THE LARGE SUPRAAORTIC VESSELS IDENTIFIES HIGHER RATES OF LARGE VESSEL INVOLVEMENT THAN PREVIOUS REPORTED IN PATIENTS WITH GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.025, https://doi.org/10.1093/rheumatology/kez058.025
086. MEMBRANOUS NEPHROPATHY SECONDARY TO PR3-ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.026, https://doi.org/10.1093/rheumatology/kez058.026
087. AN INCIDENTAL FINDING OF GIANT CELL AORTITIS-A CASE REPORT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.027, https://doi.org/10.1093/rheumatology/kez058.027
088. NOW YOU SEE ME, NOW YOU DON’T. LUNG MASSES IN GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.028, https://doi.org/10.1093/rheumatology/kez058.028
089. DIFFERENCE IN CHEST HRCT FINDINGS IN RELATION TO ANCA SUBTYPES IN ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.029, https://doi.org/10.1093/rheumatology/kez058.029
090. A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.030, https://doi.org/10.1093/rheumatology/kez058.030
091. RECURRENT CEREBRAL INFARCTION IN A CHINESE PATIENT WITH KIMURA DISEASE: A CASE REPORT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.031, https://doi.org/10.1093/rheumatology/kez058.031
092. A CASE OF GIANT CELL ARTERITIS PRESENTING RENOVASCULAR HYPERTENSION AND NEPHROTIC SYNDROME AFTER PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.032, https://doi.org/10.1093/rheumatology/kez058.032
093. ATYPICAL PRESENTATION OF ANCA-ASSOCIATED VASCULITIS: A CASE SERIES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.033, https://doi.org/10.1093/rheumatology/kez058.033
094. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.034, https://doi.org/10.1093/rheumatology/kez058.034
095. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.035, https://doi.org/10.1093/rheumatology/kez058.035
096. CONSIDERATION OF PICTURE IMAGES AND ESTABLISHMENT OF FOUNDATION KNOWLEDGE FOR ERADICATE BLINDNESS ABOUT GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.036, https://doi.org/10.1093/rheumatology/kez058.036
097. PRIMARY CENTRAL NERVOUS SYSTEM (CNS) PHLEBITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.037, https://doi.org/10.1093/rheumatology/kez058.037
098. THE NEED FOR CLASSIFICATION CRITERIA - CASE REPORT OF THE HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS SYNDROME
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.038, https://doi.org/10.1093/rheumatology/kez058.038
099. CLOSING TIME – THE CURIOUS CASE OF WIDESPREAD MEATAL ATRESIA SECONDARY TO VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.039, https://doi.org/10.1093/rheumatology/kez058.039
100. EXPLORE THE DIAGNOSTIC CRITERIA FOR TAKAYASU ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.040, https://doi.org/10.1093/rheumatology/kez058.040
101. AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) ASSOCIATED GLOMERULONEPHRITIS AND IGG4-RELATED KIDNEY DISEASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.041, https://doi.org/10.1093/rheumatology/kez058.041
102. PROPOSAL FOR A SYNOPTIC SYSTEM FOR REPORTING OF TEMPORAL ARTERY BIOPSIES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.042, https://doi.org/10.1093/rheumatology/kez058.042
103. THINKING LATERALLY IN GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.043, https://doi.org/10.1093/rheumatology/kez058.043
104. EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS REVISITED: UTILITY OF CRITERIA FOR GENUINE VASCULITIS IN CLINICAL PRACTICE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.044, https://doi.org/10.1093/rheumatology/kez058.044
105. VALUE OF MUSCLE BIOPSY IN ANCA-ASSOCIATED VASCULITIS: DIAGNOSTIC YIELD DEPENDS ON ANCA TYPE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.045, https://doi.org/10.1093/rheumatology/kez058.045
106. HISTOLOGY FOR CLASSIFICATION OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.046, https://doi.org/10.1093/rheumatology/kez058.046
107. FULLY INTEGRATED 18F-FDG PET/MR IN LARGE VESSEL VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.047, https://doi.org/10.1093/rheumatology/kez058.047
108. COMPARISON OF AORTITIS VS NON-INFLAMMATORY AORTIC ANEURYSMS AMONG PATIENTS WHO UNDERGO OPEN AORTIC ANEURYSM REPAIR
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.048, https://doi.org/10.1093/rheumatology/kez058.048
109. IMAGING ACQUISITION TECHNIQUE INFLUENCES INTERPRETATION OF POSITRON EMISSION TOMOGRAPHY VASCULAR ACTIVITY IN LARGE-VESSEL VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.049, https://doi.org/10.1093/rheumatology/kez058.049
110. CLASSIFICATION CRITERIA FOR THE ANCA-ASSOCIATED VASCULITIDES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.050, https://doi.org/10.1093/rheumatology/kez058.050
111. SENSITIVITY OF TEMPORAL ARTERY BIOPSY IN GIANT CELL ARTERITIS: SYSTEMATIC LITERATURE REVIEW AND META- ANALYSIS OF CLINICAL DATA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.051, https://doi.org/10.1093/rheumatology/kez058.051
112. VALIDATION OF RENAL ANCA SCORE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.052, https://doi.org/10.1093/rheumatology/kez058.052
113. PERFORMANCE OF ACR/EULAR PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS (AVV) IN SOUTH AMERICAN PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.053, https://doi.org/10.1093/rheumatology/kez058.053
114. A RARE ASSOCIATION OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS AND HCV INFECTION
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.054, https://doi.org/10.1093/rheumatology/kez058.054
115. CYSTIC LESION IN MYELOPEROXIDASE ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (MPO-ANCA) - POSITIVE INTERSTITIAL PNEUMONIA: RADIOLOGICAL AND PATHOLOGICAL ANALYSIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.055, https://doi.org/10.1093/rheumatology/kez058.055
116. IMMUNOHISTOLOGICAL OBSERVATION OF AORTITIS IN KAWASAKI DISEASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.056, https://doi.org/10.1093/rheumatology/kez058.056
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.057, https://doi.org/10.1093/rheumatology/kez058.057
118. VALIDATION OF THE RENAL RISK SCORE FOR ANCA-ASSOCIATED GLOMERULONEPHRITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.058, https://doi.org/10.1093/rheumatology/kez058.058
119. CARDIOVASCULAR AND VENOUS THROMBOEMBOLIC MANIFESTATIONS OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTER SERIES OF 187 PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.059, https://doi.org/10.1093/rheumatology/kez058.059
120. DIFFERENCES IN RENAL HISTOPATHOLOGY BETWEEN PR3-ANCA-ASSOCIATED VASCULITIS AND MPO-ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.060, https://doi.org/10.1093/rheumatology/kez058.060
121. MEST-C SCORE IN ADULT HENOCH-SCHÖNLEIN PURPURA NEPHRITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.061, https://doi.org/10.1093/rheumatology/kez058.061
122. DIAGNOSTIC DELAYS IN VASCULITIS AND FACTORS ASSOCIATED WITH TIME TO DIAGNOSIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.062, https://doi.org/10.1093/rheumatology/kez058.062
123. INTERNATIONAL CONSENSUS STUDY ON THE DIAGNOSIS AND MANAGEMENT OF DEFICIENCY OF ADENOSINE DEAMINASE 2 VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez058.063, https://doi.org/10.1093/rheumatology/kez058.063
EPIDEMIOLOGY
124. SPLENIC INVOLVEMENT IS NOT RARE IN ANCA-ASSOCIATED VASCULITIS; HOWEVER SPLENIC INFARCT MIGHT ONLY BE ASSOCIATED WITH GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059, https://doi.org/10.1093/rheumatology/kez059
125. NEW MAJOR ORGAN INVOLVEMENT IS LOWER IN YOUNG MALE BEHÇet’S PATIENTS COMPARED TO RETROSPECTIVE SERIES: FIVE-YEAR RESULTS OF A PROSPECTIVE COHORT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.001, https://doi.org/10.1093/rheumatology/kez059.001
126. DEVELOPMENT AND VALIDATION OF CASE-FINDING ALGORITHMS FOR THE IDENTIFICATION OF PATIENTS WITH GIANT CELL ARTERITIS AND TAKAYASU’S ARTERITIS IN LARGE HEALTHCARE ADMINISTRATIVE DATABASES
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.002, https://doi.org/10.1093/rheumatology/kez059.002
127. MULTI-METHOD CHARACTERIZATION OF INFECTION IN ANCA-ASSOCIATED VASCULITIS: RESULTS: FROM A LONGITUDINAL, MATCHED-COHORT DATA LINKAGE STUDY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.004, https://doi.org/10.1093/rheumatology/kez059.004
128. DISEASE AND TREATMENT-RELATED MORBIDITY AND COMPLICATIONS IN YOUNG AND ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.005, https://doi.org/10.1093/rheumatology/kez059.005
129. RESPIRATORY INVOLVEMENT IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: CLINICAL AND SEROLOGICAL PREDICTORS OF LONG-TERM ASTHMA SEVERITY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.006, https://doi.org/10.1093/rheumatology/kez059.006
130. CAUSE OF DEATH IN PATIENTS DIAGNOSED WITH GCA IN WESTERN NORWAY 1972-2012: A CASE-CONTROL STUDY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.007, https://doi.org/10.1093/rheumatology/kez059.007
131. SURVIVAL OF PATIENTS DIAGNOSED WITH GCA IN WESTERN NORWAY 1972-2012: A CASE-CONTROL STUDY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.008, https://doi.org/10.1093/rheumatology/kez059.008
132. COMORBID VASCULITIS AMONG PATIENTS IN A NATIONAL PRIMARY IMMUNODEFICIENCY DATABASE
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.009, https://doi.org/10.1093/rheumatology/kez059.009
133. A TEN-YEAR RETROSPECTIVE REVIEW OF TEMPORAL ARTERY BIOPSY LENGTHS IN ALBERTA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.010, https://doi.org/10.1093/rheumatology/kez059.010
134. SINGLE CENTRE EXPERIENCE OF CLINICAL PRESENTATION, MANAGEMENT AND OUTCOMES OF ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.011, https://doi.org/10.1093/rheumatology/kez059.011
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.012, https://doi.org/10.1093/rheumatology/kez059.012
136. A DECLINING TREND IN FREQUENCY OF SECONDARY AMYLOIDOSIS IN BEHÇET’S SYNDROME
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.013, https://doi.org/10.1093/rheumatology/kez059.013
137. BEHÇET DISEASE IN NORTHERN REGION OF SPAIN: PREVALENCE AND TREATMENT
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.014, https://doi.org/10.1093/rheumatology/kez059.014
138. DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.015, https://doi.org/10.1093/rheumatology/kez059.015
139. UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.016, https://doi.org/10.1093/rheumatology/kez059.016
140. THE VASCULITIS PREGNANCY REGISTRY (VPREG): BASELINE INFORMATION FOR THE FIRST 3 YEARS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.017, https://doi.org/10.1093/rheumatology/kez059.017
141. INCIDENCE OF GIANT CELL ARTERITIS IN 6 DISTRICTS OF PARIS, FRANCE (2015–2017)
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.018, https://doi.org/10.1093/rheumatology/kez059.018
142. AORTITIS CAUSED BY ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS, CASE REPORT AND LITERATURE REVIEW
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.019, https://doi.org/10.1093/rheumatology/kez059.019
143. AZATHIOPRINE HYPERSENSITIVITY SYNDROME IN A COHORT OF ANCA-ASSOCIATED VASCULITIS PATIENTS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.020, https://doi.org/10.1093/rheumatology/kez059.020
144. GEOGRAPHIC DIFFERENCES IN CLINICAL PRESENTATION AND OUTCOME OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY- ASSOCIATED VASCULITIS: ROLE OF ANTIBODY SPECIFICITY
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.021, https://doi.org/10.1093/rheumatology/kez059.021
145. EFFECTS OF PSYCHOLOGICAL STRESS ON ANCA-ASSOCIATED VASCULITIS (AAV) DIAGNOSIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.022, https://doi.org/10.1093/rheumatology/kez059.022
146. ARE CHILDHOOD-ONSET AND ADULT-ONSET TAKAYASU ARTERITIS SIMILAR IN TERMS OF CLINICAL FEATURES AND DISEASE COURSE?
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.023, https://doi.org/10.1093/rheumatology/kez059.023
147. CEREBROVASCULAR EVENT CAN BE THE PRESENTING FEATURE OF TAKAYASU ARTERITIS: RESULTS OF A PROSPECTIVE VASCULITIS CENTER
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.024, https://doi.org/10.1093/rheumatology/kez059.024
148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.025, https://doi.org/10.1093/rheumatology/kez059.025
149. PULMONARY PRESENTATIONS IN TAKAYASU ARTERITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.026, https://doi.org/10.1093/rheumatology/kez059.026
150. CLINICAL CHARACTERISTICS OF CHINESE PATIENTS WITH SYSTEMIC VASCULITIS: DATA FROM ONE CENTER OF THE CHINESE REGISTRY FOR SYSTEMIC VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez059.027, https://doi.org/10.1093/rheumatology/kez059.027
